Nurix Inc - Company Review
Nurix Inc - Company ReviewSummary
Nurix Inc (Nurix) formerly Kura Therapeutics Inc, discovers and develops drugs which work by modulating the protein regulation machinery of the cell. The company developed a drug discovery platform based on understanding of the ubiquitin proteasome system (UPS) to restore normal cellular homeostasis. Nurix also develops its proprietary Molecular Glue chemistry to identify compounds that selectively re-engage the UPS to target these harmful proteins. The company’s target therapy areas include oncology, immunology, inflammation and immuno-oncology. It has collaboration with Celgene for the discovery and development of next-generation therapies. Its funding partners include Third Rock Ventures and The Column Group. Nurix is headquartered in San Francisco, California, the US.
This comprehensive company report of Nurix Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.